Device Occlusion of Native Pulmonary Blood Flow After Cavopulmonary Anastomosis With Persistent Pleural Effusions

Sophia Khan1, Abdulla Tarmahomed1, Salim Jivanji1,2

  • 1Alder Hey Children's Hospital, Liverpool, United Kingdom.

JACC. Case Reports
|August 8, 2022
PubMed

Insights

Native pulmonary flow after cavopulmonary anastomosis can cause issues. A ventricular septal defect occluder device was used to manage prolonged pleural effusions in a young child post-surgery.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Thoracic Surgery

Background:

  • Cavopulmonary anastomosis is a surgical procedure to treat complex congenital heart defects.
  • Native pulmonary blood flow can influence pulmonary artery development but may lead to complications.
  • Prolonged pleural effusions are a known, albeit undesirable, consequence post-cavopulmonary anastomosis.

Observation:

  • A 17-month-old child experienced persistent pleural effusions following a cavopulmonary anastomosis.
  • The child had a ventricular septal defect, which was managed during the surgical course.
  • An occluder device, typically used for ventricular septal defects, was placed in the native right ventricular outflow tract.

Findings:

  • The placement of a ventricular septal defect occluder device in the native right ventricular outflow tract was a novel approach.
  • This intervention was performed in the context of managing prolonged pleural effusions post-cavopulmonary anastomosis.
  • The case highlights an advanced application of device closure in a complex pediatric cardiac surgical scenario.

Implications:

  • This case suggests a potential, albeit unconventional, therapeutic option for managing specific complications after cavopulmonary anastomosis.
  • Further investigation is warranted to understand the efficacy and safety of using VSD occluders in the native RVOT for pleural effusion management.
  • This approach may offer insights into alternative strategies for optimizing outcomes in complex pediatric cardiac surgery.

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.7K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
317
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
3.0K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
256
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K